ORATONIN Trademark

Trademark Overview

On Tuesday, April 9, 2002, a trademark application was filed for ORATONIN with the United States Patent and Trademark Office. The USPTO has given the ORATONIN trademark a serial number of 78120493. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Sunday, August 27, 2006. This trademark is owned by Nobex Corporation. The ORATONIN trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparation of chemically modified oral calcitonin for the treatment of osteoporosis

General Information

Serial Number78120493
Word MarkORATONIN
Filing DateTuesday, April 9, 2002
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateSunday, August 27, 2006
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, June 3, 2003

Trademark Statements

Goods and Servicespharmaceutical preparation of chemically modified oral calcitonin for the treatment of osteoporosis

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, April 15, 2002
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNobex Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressResearch Triangle Park, NC 27709
Party NameNobex Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressResearch Triangle Park, NC 27709

Trademark Events

Event DateEvent Description
Tuesday, October 31, 2006ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Tuesday, October 31, 2006ABANDONMENT - NO USE STATEMENT FILED
Tuesday, February 14, 2006EXTENSION 5 GRANTED
Tuesday, February 14, 2006EXTENSION 5 FILED
Tuesday, February 14, 2006TEAS EXTENSION RECEIVED
Friday, August 12, 2005EXTENSION 4 GRANTED
Friday, August 12, 2005EXTENSION 4 FILED
Friday, August 12, 2005TEAS EXTENSION RECEIVED
Monday, March 28, 2005TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, March 25, 2005EXTENSION 3 GRANTED
Friday, February 18, 2005EXTENSION 3 FILED
Friday, February 18, 2005TEAS EXTENSION RECEIVED
Thursday, August 19, 2004EXTENSION 2 GRANTED
Thursday, August 19, 2004EXTENSION 2 FILED
Thursday, August 19, 2004TEAS EXTENSION RECEIVED
Tuesday, August 17, 2004CASE FILE IN TICRS
Monday, July 19, 2004PAPER RECEIVED
Friday, July 16, 2004TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, June 21, 2004FAX RECEIVED
Tuesday, March 2, 2004EXTENSION 1 GRANTED
Friday, February 20, 2004EXTENSION 1 FILED
Friday, February 20, 2004TEAS EXTENSION RECEIVED
Tuesday, August 26, 2003NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 3, 2003PUBLISHED FOR OPPOSITION
Wednesday, May 14, 2003NOTICE OF PUBLICATION
Tuesday, April 8, 2003APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, January 27, 2003CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, March 27, 2003ASSIGNED TO EXAMINER
Monday, January 27, 2003PAPER RECEIVED
Wednesday, January 29, 2003CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, July 29, 2002NON-FINAL ACTION E-MAILED
Friday, July 26, 2002ASSIGNED TO EXAMINER

Related Keywords

oratonin calcitonin treatment osteoporosis oral modified preparation chemically pharmaceutical